Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

অনুরূপ উপাদানগুলি

• Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
  অনুযায়ী: Meletios A. Dimopoulos, অন্যান্য
  প্রকাশিত: (2015-10-01)
• Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma
  অনুযায়ী: Jesus F. San Miguel, অন্যান্য
  প্রকাশিত: (2015-10-01)
• Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma
  অনুযায়ী: Kevin W. Song, অন্যান্য
  প্রকাশিত: (2015-02-01)
• Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma
  অনুযায়ী: Despina Fotiou, অন্যান্য
  প্রকাশিত: (2022-05-01)
• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma
  অনুযায়ী: Aleksei Vladilenovich Petrov, অন্যান্য
  প্রকাশিত: (2017-07-01)